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Copyright © 2010 JCBN Summary Helicobacter pylori (HP)-eradication therapy increases Runt domain transcription
factor 3 (RUNX3) expression in the glandular epithelial cells in enlarged-fold gastritis. The
aim of this study is to evaluate expression of the RUNX3 protein, the product of a gastric
tumor suppression gene, and mutagenic oxidative stress in human gastric mucosal specimens
obtained from patients with HP-induced enlarged-fold gastritis. Methods. RUNX3 expression
was immunohistochemically scored and the degree of the mucosal oxidative stress was directly
measured by the chemiluminescense (ChL) assay in the biopsy specimens. Results. RUNX3
expression was detected in the gastric epithelial cells. HP-eradication significantly increased
RUNX3 expression in the glandular epithelium of the corpus, however, no change was
observed in those of the antrum. A fourfold higher mucosal ChL value was observed in the
corpus as compared with that in the antrum. HP-eradication significantly decreased the
mucosal ChL values in both portions of the stomach to nearly undetectable levels. Conclusion.
The glandular epithelium is exposed to a high level of carcinogenic oxidative stress and shows
low levels of expression of the tumor suppressive molecule, RUNX3; however, this expression
was restored after HP-eradication, suggesting the high risk of carcinogenesis associated with
HP-induced enlarged-fold gastritis of the corpus.
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Introduction
Gastric cancer is the most prevalent gastrointestinal (GI)
malignancy in Japan, while in other developed countries,
the prevalence of colon cancer is higher than that of gastric
cancer. Recent clinical studies have clearly demonstrated
that patients with chronic gastritis associated with Helico-
bacter pylori (HP) infection have an approximately three-
fold higher risk of developing gastric cancer than those
without HP infection [1]. Furthermore, eradication of HP
infection by antibiotics has been shown to be associated
with a definite decrease in the risk of gastric cancer [2, 3].
Thus, while the carcinogenic role of HP is now widely
accepted, the underlying pathogenetic mechanism remains
to be clarified. Recently, enlarged-fold gastritis has attracted
much attention, because the risk of carcinogenesis associated
with this type of gastritis has been suggested to be much
higher than that associated with atrophic gastritis, the
commonly observed type of chronic gastritis in the Japanese
population [4]. This type of gastritis is characterized by
enhanced inflammation of the corpus mucosa, however theM. Suzuki et al.
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mechanism involved in the carcinogenic potential of this
type of gastritis has not been fully elucidated.
Oxidative stress, now acknowledged as one of the major
carcinogenic process, directly modifies genetic nucleotides,
followed by activation of many tumor suppressor genes [5].
On the other hand, the Runt domain transcription factors
(RUNX) have also been linked to gastric cancer develop-
ment [6]. Among the members of the RUNX family,
RUNX3 has been proposed as a gastric tumor suppressor
gene and its activity has been shown to be influenced by
DNA methylation [7].
This study was aimed at clarifying the carcinogenic
mechanism of enlarged-fold gastritis by measuring the
levels of oxidative stress and RUNX3 expression in the
gastric mucosa of patients with HP-induced enlarged-fold
gastritis.
Methods
Patients and sampling
Thirteen patients with HP-induced enlarged-fold gastritis
(fold width ≥5 mm) who visited the Gastroenterology Divi-
sion of the National Hospital Organization Tokyo Medical
Center with upper GI symptoms were enrolled in this study.
All of the subjects provided written informed consent for
this study, and the study protocol was approved by the Ethics
Committee of Tokyo Medical Center. Upper GI endoscopy
was performed in the patients. Two biopsy specimens were
obtained from the antrum and two from greater curvature of
the upper corpus. One of these was processed for histo-
logical assessment (Hematoxylin-Eosin stain (HE) and
immunohistochemistry for RUNX3) and the other was used
for assay of oxygen-free radical production. Eradication
for HP was performed using routine one week course of
triple therapy with proton pump inhibitor, clarithromycin,
and amoxicillin. Success of eradication therapy was con-
firmed by 13C-urea breath test.
Histological assessment
Immunohistochemistry for RUNX3 was performed ac-
cording to a previously described method. [8] The histo-
logical assessment was performed in a blinded manner,
and the degree of staining in the surface epithelial cells and
glandular epithelial cells was scored as follows: intensity
of gastric RUNX3 expression was graded in the epithelial
cells of the mucosa as follows: 0 (negative), 1 (<33% cells
showing positive staining), 2 (33–66% cells showing posi-
tive staining), or 3 (>66% cells showing positive staining).
The degree of inflammatory cell infiltration was scored on
the HE-stained sections according to the Updated Sydney
System [9].
Oxygen-derived free radical measurement
Luminol-dependent chemiluminescence (ChL) assay was
used for direct assessment of oxygen-derived free radical
production from the gastric mucosa, according to a pre-
viously reported method [10, 11]. Briefly, biopsy specimens
(approximately 10 mg in wet weight) were placed, immedi-
ately after sampling, in a scintillation vial containing 0.5 ml
of Eagle’s minimum essential medium (MEM; pH 7.4) and
20 μg of luminol. The average ChL value (count/10 s/mg
wet weight) for the first 5 min was used for the analysis.
Statistical analysis
All the data were expressed as mean ± SD and analyzed
by Wilcoxon’s rank sum test. Significance was set at p<0.05.
Results
Endoscopic appearance
The characteristic endoscopic features of enlarged-fold
gastritis are shown in Fig. 1. Before the HP eradication,
enlarged folds with thick mucus were observed in the greater
curvature at the corpus, which clearly improved after HP
eradication therapy.
RUNX3 expression in the gastric mucosa
The results of immunohistochemistry for RUNX3 protein
in the gastric mucosa are illustrated in Fig. 2 (antrum) and
Fig. 3 (corpus). In the antrum, RUNX3 protein expression
was observed in the epithelial cells as well as the infiltrating
leukocytes. Although the nuclei of epithelial cells were
counterstained with hematoxylin, strong RUNX3 expression
was still observed in some nucleus. While high immuno-
reactivity was observed in the infiltrating leukocytes,
dramatic weakening of the staining intensity was observed
after HP eradication. High level of the RUNX3 expression
was also observed in the glandular epithelium in the corpus,
which further increased following HP eradication.
Figs. 4 and 5 show the immunohistochemical scores for
RUNX3 expression in the epithelial cells. Semi-quantitative
analysis demonstrated that the RUNX3 expression in the
surface epithelium was unchanged following HP eradication
(antrum: 1.15 ± 0.55 to 1.00 ± 0.41, n.s., corpus: 1.31 ± 0.63
to 1.08 ± 0.28, n.s.). While no increase of the protein expres-
sion in the glandular epithelium was also observed in the
antrum (1.38 ± 0.65 to 1.54 ± 0.52, n.s.), that in the corpus
significantly increased following HP eradication (1.85 ± 0.55
to 2.54 ± 0.52, p<0.01).
Table 1 shows the leukocyte infiltration score as assessed
according to the Updated Sydney System. Significant
decrease in the number of infiltrating leukocytes (poly-
morphonuclear and mononuclear cells) was observed
following HP eradication.
Fig. 6 illustrates the ChL activity of the gastric mucosa,Enlarged-Fold Gastritis and Carcinogenesis
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which is a direct measure of oxidative stress. The ChL value
was fourfold higher in the corpus mucosa as compared with
that in the antral mucosa. Significant decrease of the ChL
values to undetectable levels was observed in both portions
of the gastric mucosa after HP eradication (antrum: 72.7 ±
110 to 2.89 ± 0.94,  p<0.01; corpus: 309 ± 251 to 3.90 ±
1.92, p<0.01).
Discussion
Gastric carcinoma is reported as the first or second
leading cause of cancer-related death in Japan. HP infection
now generally accepted as one of the major factors involved
in the development of gastric carcinoma. This bacterium
reportedly modifies the cellular functions related to cell
growth, which is mainly regulated by the cagA-protein [12].
Nishibayashi  et al. reported detecting enlarged-fold
gastritis (fold width ≥5 mm) in 81% of patients with gastric
carcinoma, while it was detected in only 46% of HP-positive
controls. Furthermore, mucosal levels of 8-OHdG, another
measure of oxidative stress, were higher in specimens from
enlarged-fold gastritis than those in the controls [13]. The
finding in the present study of enhanced levels of oxidative
stress as measured by tissue-associated ChL activity lend
Fig. 1. Endoscopic images before (A) and after (B) HP eradication in patients with enlarged-fold gastritis. HP eradication was followed
by a reduction of the enlarged folds with thick mucus.
Fig. 2. Immunohistochemistry for RUNX3 protein expression in the antral mucosa pre-(A) and post-(B) HP eradication (counterstain-
ing was also done with hematoxylin). Pre-eradication, RUNX3 expression was observed in epithelial cells as well as infiltrating
leukocytes, and the strong expression was observed in the nuclei of the epithelial cells. Post-eradication, no significant change
was observed in the surface and glandular epithelium.M. Suzuki et al.
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Fig. 3. Immunohistochemistry for RUNX3 protein expression in the corpus mucosa pre-(A) and post-(B) HP eradication (counterstain-
ing was also done with hematoxylin). Pre-eradication, strong RUNX3 expression was observed in the epithelial cell as well as
infiltrating leukocytes. Post-eradication, RUNX3 expression was not changed in the surface epithelial cells, while the increase
was observed in the glandular epithelium.
Fig. 4. Histological score for RUNX3 expression in the antral
epithelial cells pre- and post-HP eradication. The protein
expression in the surface and glandular epithelial cells
was unchanged after HP eradication.
Fig. 5. Histological score for RUNX3 expression in the corpus
epithelial cells pre- and post-HP eradication. RUNX3
expression in the glandular epithelial cells increased
significantly after HP eradication (*p<0.01), while that
in the surface epithelium was unchanged.
Table 1. Alterations of the histological score pre- and post-HP eradication in patients with enlarged-fold corpus
gastritis.
 (n = 13) PMN: polymorphonuclear cell, Mo: mononuclear cell.
Antrum Corpus
PMN Mo PMN Mo
Pre-eradication 1.23 ± 0.73 1.92 ± 0.76 2.00 ± 0.82 2.23 ± 0.60
Post-eradication 0.46 ± 0.66 1.31 ± 0.95 0.46 ± 0.88 0.62 ± 0.87
p value n.s. n.s. p<0.01 p<0.01Enlarged-Fold Gastritis and Carcinogenesis
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support to these previous reports. Our previous data
demonstrated that the corpus ChL activity in HP-positive
non-enlarged-fold gastritis (DU and GU) was approximately
70% lower than that in enlarged-fold gastritis [10]. Since
this enhanced ChL activity was dramatically reduced by
eradication of HP, it was considered that elevated levels of
oxidative free radical production may be one of the possible
carcinogenic mechanisms resulting in gastric cancer.
Significant reduction in the degree of inflammatory cell
infiltration (polymorphonuclear and mononuclear cells) was
also observed (antrum: 30–60%, corpus: 70–75% reduction)
following HP eradication, although the magnitude of this
decrease was much lower than that of ChL, suggesting that
enhanced oxidative stress caused by HP infection may be
regulated by not only the number of inflammatory cells, but
also by other factors, including the activity of each leukocyte
and tissue anti-oxidant molecules.
The Runt domain transcription factors (RUNX1, 2 and 3)
have been reported to play key roles in developmental path-
ways in mammalian cells. Among this gene family, RUNX3
has been proposed as a gastric tumor suppressor gene.
Enhanced expression of RUNX3 has been demonstrated to
inhibit gastric carcinoma cell growth in vitro, as well as
tumorigenicity and metastasis [14, 15]. Friedrich et al. [16]
examined RUNX3 protein expression in HP-infected non-
cancerous gastric mucosa and found that the protein expres-
sion was prominently detected in the infiltrating leukocytes
in the lamina propria, but not in the human gastric epithe-
lium, as confirmed by a low mRNA expression in quantita-
tive reverse transcriptase-polymerase chain reaction (RT-
PCR). However, Nakase et al. [17] demonstrated RUNX3
expression in the normal epithelial cells of the remnant
stomach by in situ hybridization as well as RT-PCR. Ito et al.
[8] performed immunohistochemical staining of RUNX3 in
the normal human stomach epithelial cells with R3-6E9, and
found that while the chief cells and surface epithelial cells
were strongly stained, the parietal cells showed only weak
staining. In the present study, RUNX3 expression was
clearly detected in the gastric epithelium as well as infil-
trating leukocytes. Furthermore, semi-quantitative analysis
revealed no significant change of RUNX3 expression in
the surface epithelial cells, whereas a significant increase
of the protein expression was observed in the glandular
epithelium of the corpus, which is composed of chief cells
and parietal cells, after HP eradication.
RUNX3 expression has often been reported to be down-
regulated in human gastric carcinoma owing to epigenetic
silencing by promoter hypemethylation [7]. Kim et al. [18]
demonstrated RUNX3 methylation in 8.1% of chronic
gastritis specimens, 28.1% of intestinal metaplasia speci-
mens, 27.3% of gastric adenoma specimens and 64% of
gastric carcinoma specimens, suggesting increase of RUNX3
methylation with progression of the lesion along the path
of multistep gastric carcinogenesis. Kitajima et al. [ 19]
reported that RUNX3 methylation is induced by HP infec-
tion, and that subsequent loss of RUNX3 expression may
affect gastric carcinogenesis. Miyazaki et al. [20] found a
decrease of the immunoreactivity for E-cadherin in HP-
positive patients with enlarged-fold gastritis as compared
with that in HP-negative patients, and suggested that this
reduction might be due to the high methylation percentage
of E-cadherin.
DNA methylation is closely associated with free radical
injury [21], and methylation of E-cadhelin has been shown
to be enhanced by reactive oxygen species (ROS) [19]. In
the present study, extensive increase of the oxidative stress
in the corpus mucosa was demonstrated, thus RUNX3
expression may be partially downregulated by oxidant-
induced DNA methylation. Further study including direct
assessment of methylation process is necessary to clarify
this issue.
In the present study, RUNX3 immunoreactivity was
restored in the corpus glandular epithelium (probably chief
cells) after HP eradication, while those in the other epithe-
lium were unchanged. It is postulated that greater RUNX3
gene methylation may be induced in the glandular epithe-
lium than in the surface epithelium by HP infection,
resulting in a relatively lower expression level of RUNX3
in the glandular epithelium than in the surface epithelium,
lending support to the hypothesis that carcinogenic trans-
formation may occur more frequently in the glandular
epithelium than in the surface epithelium in HP-induced
enlarged-fold gastritis.
In conclusion, the low level of RUNX3 expression in the
glandular epithelium and high level of oxidative stress in the
corpus mucosa may contribute to the high risk of carcino-
genesis associated with enlarged-fold gastritis.
Fig. 6. Chemiluminescence (ChL) activity of the gastric mucosa
(antrum and corpus) pre- and post-HP eradication.
Marked ChL activity was observed in the corpus
mucosa, which decreased dramatically after HP eradica-
tion. (*p<0.01 compared to each pre-eradication value)M. Suzuki et al.
J. Clin. Biochem. Nutr.
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